About this episode

The episode discusses cytomegalovirus management in immunocompromised hematology patients with expert guests.

Join hosts Eddie, Ashwin, and Raj as they welcome Dr. Michelle Yong and Dr. Gemma Reynolds, academic infectious diseases physicians from the Peter MacCallum Cancer Centre and the National Centre for Infections in Cancer, for an in-depth discussion on cytomegalovirus (CMV) management in immunocompromised hematology patients. Key Topics Covered Fundamentals of CMV Management Distinguishing CMV reactivation from CMV disease Treatment thresholds and target viral loads Prophylaxis strategies in non-allograft settings Valaciclovir dosing in general hematology populations High-risk patient populations First-Line Therapies Valganciclovir: advantages, disadvantages, and myelosuppression Foscarnet: indications and monitoring strategies Treatment-resistant CMV Allogeneic Transplant Patients High-risk populations and timing of reactivation Monitoring protocols post-transplant Randomized Controlled Trials AURORA Trial: Maribavir vs. Valganciclovir Design: RCT comparing maribavir to valganciclovir for pre-emptive CMV therapy post-allogeneic transplant [https://pubmed.ncbi.nlm.nih.gov/38036487/] NEJM Letermovir Prophylaxis Trial Design: Double-blind, placebo-controlled RCT of letermovir…

People in this episode

Hosts: Eddie, Ashwin, Raj

Guests: Dr. Michelle Yong, Dr. Gemma Reynolds

Topics covered

• CMV management
• hematologic malignancies
• immunocompromised patients
• treatment strategies
• prophylaxis
• clinical trials

Keywords

• cytomegalovirus
• CMV reactivation
• valaciclovir
• valganciclovir
• allogeneic transplant
• CAR T-cell therapy
• prophylaxis strategies

Mentioned in this episode

Organizations: Peter MacCallum Cancer Centre, National Centre for Infections in Cancer

More episodes of Blood Cancer Talks

• Episode 70. ASH 2025 Myeloid Neoplasm Roundup with Dr. Curtis Lachowiez · February 27, 2026 · 57 min
• Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo · January 22, 2026 · 44 min
• Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa · January 2, 2026 · 46 min
• Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza · October 15, 2025 · 52 min
• Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain · September 24, 2025 · 53 min
• Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson · August 20, 2025 · 43 min

Explore listener stats, chart rankings, contacts and more on the Blood Cancer Talks podcast page.